Morgan Stanley Biotricity Inc. Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.44 - $0.88 $2 - $5	-6 Reduced 1.4%	424 $0
Q3 2022 Nov 14, 2022	BUY	$0.9 - $1.75 $1 - $3	2 Added 0.47%	430 $0
Q2 2022 Oct 27, 2022	SELL	$0.96 - $2.36 $3,896 - $9,579	-4,059 Reduced 90.46%	428 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.96 - $2.36 $3,896 - $9,579	-4,059 Reduced 90.46%	428 $1,000
Q1 2022 Oct 27, 2022	BUY	$2.27 - $4.03 $9,213 - $16,357	4,059 Added 948.36%	4,487 $10,000

Q1 2022 May 13, 2022	BUY	$2.27 - $4.03 $887 - $1,575	391 Added 9.55%	4,487 $10,000
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.67 $9,188 - $15,892	3,403 Added 491.05%	4,096 $16,000
Q3 2021 Nov 15, 2021	BUY	$2.91 - $3.79 $2,016 - $2,626	693 New	693 $2,000

857

Ticker BTCY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 50,431,200
Market Cap $38.8M
Description
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.